Status:
ACTIVE_NOT_RECRUITING
The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"
Lead Sponsor:
International Agency for Research on Cancer
Collaborating Sponsors:
World Health Organization
University of KwaZulu
Conditions:
HPV Infection
Eligibility:
FEMALE
25-54 years
Phase:
PHASE3
Brief Summary
The main objectives of CESTA are (1) to compare the efficacy of two cervical cancer screening algorithms: HPV test followed by visual inspection with acetic acid (VIA) and treatment (HPV + VIA + treat...
Eligibility Criteria
Inclusion
- Willing to disclose HIV status
- HIV negative women aged 30-54 years; HIV positive women aged 25-54 years
- Mentally competent to give informed consent
- Physically able to have a pelvic exam
Exclusion
- Women reporting no previous sexual activity
- History of cervical cancer
- Treatment for cervical precancer in the last six months
- Hysterectomy
- Pregnancy
- Serious pre-existing medical conditions (e.g. history of bleeding disorders, serious physical or mental disease)
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04794660
Start Date
October 1 2019
End Date
October 1 2025
Last Update
March 13 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Roi Baudoin hospital
Dakar, Senegal
2
Wentworth Hospital
Durban, South Africa
3
Frere Hospital
East London, South Africa